Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril
Reference:
Gliddon, A. E., Doré, C. J., Black, C. M., McHugh, N. J., Moots, R., Denton, C. P., Herrick, A., Barnes, T., Camilleri, J., Chakravarty, K., Emery, P., Griffiths, B., Hopkinson, N. D., Hickling, P., Lanyon, P., Laversuch, C., Lawson, T., Mallya, R., Nisar, M., Rhys-Dillon, C., Sheeran, T. and Maddison, P. J., 2007. Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis & Rheumatism, 56 (11), pp. 3837-46.
Related documents:
This repository does not currently have the full-text of this item.You may be able to access a copy if URLs are provided below.
Official URL:
http://dx.doi.org/10.1002/art.22965
Abstract
Administration of quinapril for up to 3 years had no demonstrable effects on the occurrence of upper limb digital ulcers or on other vascular manifestations of lcSSc in this patient population.
Details
| Item Type | Articles |
| Creators | Gliddon, A. E., Doré, C. J., Black, C. M., McHugh, N. J., Moots, R., Denton, C. P., Herrick, A., Barnes, T., Camilleri, J., Chakravarty, K., Emery, P., Griffiths, B., Hopkinson, N. D., Hickling, P., Lanyon, P., Laversuch, C., Lawson, T., Mallya, R., Nisar, M., Rhys-Dillon, C., Sheeran, T. and Maddison, P. J. |
| DOI | 10.1002/art.22965 |
| Departments | Faculty of Science > Pharmacy & Pharmacology Faculty of Humanities & Social Sciences > Health |
| Refereed | Yes |
| Status | Published |
| ID Code | 27948 |
Export
Actions (login required)
| View Item |
